CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FierceBiotech
Original article

{"a":[{"_":"Boehringer places phase 1 study of investigational drug on hold to examine ‘safety event’","$":{"href":"/biotech/boehringer-benches-phase-1-study-safety-event","hreflang":"en"}}]}

Phase 1negativeNegative
AI Analysis

Summary

Boehringer Ingelheim has suspended a Phase 1 trial of an investigational small molecule drug due to a safety event. The company has not disclosed details about the nature of the incident.

Clinical Trial Data

Phase

1

Outcome Details

Phase 1 trial suspended due to safety event

Importance:6/10
Sentiment:
-0.70
safetytrial suspensionphase 1investigational drug

Read the original article

Published by FierceBiotech on August 20, 2026 3:10 PM

Read Original